$0.2530
0.0210.00%
At close: -
$0.2520
-0.00100-0.40%
After Hours: 6:55 PM EDT
Comments
Loading...
cbdMD Earnings Estimates, EPS & Revenue | AMEX:YCBD | Benzinga
cbdMD reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.360
Quarterly Revenue Estimate
$5.25M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$19.22M
Analyze the earnings history of cbdMD using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| YCBD | cbdMD | -$1.35 | -$0.36 | — | — | $4.38M | $5.25M | — | — | 05/14/2025 | Get Alert |
| YCBD | cbdMD | -$0.67 | — | -$0.22 | — | $5.38M | — | $5.11M | — | 02/13/2025 | Get Alert |
| YCBD | cbdMD | -$9.06 | $0.00 | -$0.18 | -100.00% | $5.71M | $4.81M | $4.56M | -5.28% | 12/18/2024 | Get Alert |
| YCBD | cbdMD | -$1.16 | -$0.62 | -$0.15 | 75.81% | $6.12M | $4.93M | $5.17M | 4.95% | 08/14/2024 | Get Alert |
| YCBD | cbdMD | -$1.74 | -$0.75 | -$1.35 | -80.00% | $6.24M | $5.40M | $4.38M | -18.94% | 05/15/2024 | Get Alert |
| YCBD | cbdMD | -$3.60 | -$0.74 | -$0.67 | 9.46% | $6.08M | $5.80M | $5.38M | -7.33% | 02/13/2024 | Get Alert |
| YCBD | cbdMD | -$11.25 | — | -$9.06 | — | $7.86M | — | $5.71M | — | 12/22/2023 | Get Alert |
| YCBD | cbdMD | -$24.75 | — | -$1.16 | — | $8.59M | — | $6.12M | — | 08/10/2023 | Get Alert |
| YCBD | cbdMD | -$4.50 | — | -$1.74 | — | $9.63M | — | $6.24M | — | 05/15/2023 | Get Alert |
| YCBD | cbdMD | -$3.60 | — | -$3.60 | — | $9.32M | $11.50M | $6.08M | -47.09% | 02/13/2023 | Get Alert |
| YCBD | cbdMD | -$1.80 | — | -$11.25 | — | $9.79M | — | $7.86M | — | 12/15/2022 | Get Alert |
| YCBD | cbdMD | -$0.45 | — | -$24.75 | — | $10.56M | — | $8.59M | — | 08/11/2022 | Get Alert |
| YCBD | cbdMD | -$2.25 | — | -$4.50 | — | $11.80M | $10.00M | $9.63M | -3.72% | 05/13/2022 | Get Alert |
| YCBD | cbdMD | -$0.45 | -$0.90 | -$3.60 | -300.00% | $12.33M | $13.25M | $9.32M | -29.65% | 02/10/2022 | Get Alert |
| YCBD | cbdMD | -$7.20 | -$1.80 | -$1.80 | 0.00% | $11.70M | $11.25M | $9.79M | -12.95% | 12/17/2021 | Get Alert |
| YCBD | cbdMD | -$8.10 | -$1.80 | -$0.45 | 75.00% | $10.64M | $13.40M | $10.56M | -21.19% | 08/12/2021 | Get Alert |
| YCBD | cbdMD | $18.90 | -$1.35 | -$2.25 | -66.67% | $9.40M | $12.63M | $11.80M | -6.58% | 05/12/2021 | Get Alert |
| YCBD | cbdMD | $20.25 | -$0.45 | -$0.45 | 0.00% | $10.15M | $11.98M | $12.33M | 2.90% | 02/09/2021 | Get Alert |
| YCBD | cbdMD | $0.00 | -$0.45 | -$7.20 | -1500.00% | $8.69M | $11.20M | $11.70M | 4.46% | 12/22/2020 | Get Alert |
| YCBD | cbdMD | -$49.50 | -$1.35 | -$8.10 | -500.00% | $8.04M | $9.57M | $10.64M | 11.15% | 08/12/2020 | Get Alert |
| YCBD | cbdMD | -$4.05 | -$3.60 | $18.90 | 625.00% | $5.67M | $11.33M | $9.40M | -17.04% | 05/18/2020 | Get Alert |
cbdMD (YCBD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-12-18 | $-0.18 | $0 | -100.0 % |
| Q3 | 2024-08-14 | $-0.15 | $-0.62 | 75.8 % |
| Q2 | 2024-05-15 | $-1.35 | $-0.75 | -80.0 % |
| Q1 | 2024-02-13 | $-0.67 | $-0.74 | 9.46 % |
cbdMD (YCBD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2024-12-18 | $4.56M | $4.81M | -5.28 % |
| Q3 | 2024-08-14 | $5.17M | $4.93M | 4.95 % |
| Q2 | 2024-05-15 | $4.38M | $5.40M | -18.9 % |
| Q1 | 2024-02-13 | $5.38M | $5.80M | -7.33 % |
FAQ
When is cbdMD (AMEX:YCBD) reporting earnings?
cbdMD (YCBD) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on February 13, 2025 for Q1.
What were the latest earnings per share (EPS) for cbdMD (AMEX:YCBD)?
The Actual EPS was $-0.22, which missed the estimate of $0.00.
What were cbdMD’s (AMEX:YCBD) revenues?
The Actual Revenue was $5.1M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.